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Summary
 
Antibodies to single-stranded (ss)DNA are expressed in patients with systemic lupus erythema-
tosus and in lupus-prone mouse models such as the MRL/Mp-
 
lpr/lpr
 
 (MRL/
 
lpr
 
) strain. In
nonautoimmune mice, B cells bearing immunoglobulin site-directed transgenes (sd-tgs) that
code for anti-ssDNA are functionally silenced. In MRL/
 
lpr
 
 autoimmune mice, the same sd-tgs
are expressed in peripheral B cells and these autoantibodies gain the ability to bind other au-
toantigens such as double-stranded DNA and cell nuclei. These new specificities arise by so-
matic mutation of the anti-ssDNA sd-tgs and by secondary light chain rearrangement. Thus, B
cells that in normal mice are anergic can be activated in MRL/
 
lpr
 
 mice, which can lead to the
generation of pathologic autoantibodies. In this paper, we provide the first direct evidence for
peripheral rearrangement in vivo.
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T
 
he autoantibody specificities in SLE are biased toward
DNA and nucleoproteins (1). These autoantibodies,
known collectively as antinuclear antibodies (ANAs),
 
1
 
 are
diagnostic of SLE, but individuals with this disease express
unique subsets of ANAs (2). The limited spectra of autoan-
tibodies, both in the general population and among indi-
viduals with SLE, suggest that these autoantibodies arise by
immunization (2). The oligoclonality of autoantibodies in
SLE and other systemic autoimmune diseases of humans
and mice confirms that autoantibodies arise by antigen acti-
vation (3, 4). The subsets of autoantibodies expressed by
SLE patients are often directed to “physically-linked epi-
topes,” for example, DNA and histones (5). Because it is
unlikely that a pathogen would mimic multiple self-
epitopes, autoantibodies to linked epitopes argue that the
immunogens in SLE are complex structures, such as nu-
cleosomes, made up of DNA and DNA binding proteins.
Interestingly, complex antigens containing the common
targets of SLE autoantibodies, such as DNA, Ro, and La,
are found in blebs on the surface of dying cells (6). These
blebs could be the delivery vehicles of self-antigen, espe-
cially in tissues undergoing extensive apoptosis.
That autoantibodies directed against ubiquitous self-anti-
gens such as DNA resemble antibodies to foreign antigens
implies that all individuals have the potential for generating
these specificities. Hence, autoreactive B cells must be un-
der active, negative regulation in nonautoimmune individ-
uals. Mice with transgenes coding for autoantibodies have
been useful tools for studying self-tolerance and have dem-
onstrated that this is the case; B cells specific for facultative
or constitutive self-antigens undergo receptor editing, be-
come anergic, or, if all else fails, are deleted (7–14). The use
of these models has been extended to the study of why self-
tolerance fails in autoimmune disease, and autoantibody
transgenes have been crossed to MRL/
 
lpr
 
 and 
 
lpr/lpr
 
 con-
genic mice for this purpose (15–19). The 
 
lpr
 
 mutation inac-
tivates the Fas receptor (CD95), thereby protecting Fas-
sensitive cells from programmed cell death (for review see
reference 20). Thus, the extent to which Fas-dependent
apoptosis contributes to the regulation of autoreactive B
cells is testable in these transgenic 
 
lpr/lpr
 
 mice.
The transgenes directed to the facultative self-antigens,
hen egg lysozyme (HEL) and an MHC product, H-2K
 
k
 
,
have yielded unexpected results. Central tolerance to H-2K
 
k
 
1
 
Abbreviations used in this paper:
 
 ANA, antinuclear antibody; dsDNA, dou-
ble-stranded DNA; FW, framework; HEL, hen egg lysozyme; MRL/
 
lpr
 
,
MRL/Mp-
 
lpr/lpr
 
 mouse; RAG, recombination-activating gene; sd-tg,
site-directed transgene; ssDNA, single-stranded DNA. 
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and the membrane form of HEL, which is achieved by
elimination of the specificities for these antigens, appears to
be intact in anti–H-2K and anti-HEL 
 
lpr/lpr
 
 mice (15, 17).
Also, tolerance to the soluble forms of HEL and MHC was
not broken in 
 
lpr/lpr
 
 mice (15, 16). However, in transgenic
anti-DNA 
 
lpr/lpr
 
 mice, tolerance to DNA is broken (18).
Hence, a selective breakdown of tolerance may explain the
limited spectrum of autoantibodies seen in MRL/
 
lpr
 
 or 
 
lpr/lpr
 
congenics, a spectrum that includes anti-DNA but not
anti-H2. Selective breakdown of tolerance could be ex-
plained by the affinity of the receptor for self-antigen, fea-
tures of the self-antigen such as concentration, or by the
chronology of antigen presentation. The previous study on
anti-DNA transgenic 
 
lpr/lpr
 
 mice (18) was not informative
in this regard because the level and time at which tolerance
to DNA was broken could not be ascertained. Here we de-
scribe studies on an anti–single-stranded (ss)DNA trans-
genic 
 
lpr/lpr
 
 mouse in which the specificity of the anti-
DNA is explicitly known (12, 21) and the mechanism of
regulation in normal mice is understood in detail (13). Our
studies show that anti-DNA expression in 
 
lpr/lpr
 
 mice is
due to a combination of loss of peripheral tolerance (an-
ergy) and inappropriate activation of defunct B cells.
 
Materials and Methods
 
Mice.
 
The construction of site-directed transgenic (sd-tg)
mice expressing the H and/or L chain genes coding for well-
defined anti-DNA Abs has been described previously (22, 23).
BALB/c 3H9V
 
k
 
8 sd-tg mice (3H9V
 
k
 
8/BALB/c) were crossed
onto the MRL-
 
lpr/lpr
 
 background and backcrossed three times to
generate 3H9V
 
k
 
8 MRL-
 
lpr/lpr
 
 mice (3H9V
 
k
 
8/
 
lpr
 
). Animals ho-
mozygous for the 
 
lpr 
 
gene were identified by two PCR assays us-
ing tail DNA. In brief, 1–2 mm of tail was snipped off and placed
into 80 
 
m
 
l tail digestion buffer (50 mM Tris-HCl, pH 8.0, 50 mM
KCl, 2.5 mM EDTA, 0.45% NP-40, and 0.45% Tween 20) con-
taining 2 
 
m
 
l proteinase K (20 mg/ml; Boehringer Mannheim).
After overnight incubation at 55
 
8
 
C, tail samples were boiled for
10 min and kept on ice. 1 
 
m
 
l of tail DNA was used for both PCR
assays. The oligonucleotides used for these PCRs have been de-
scribed previously (24). They were Fas-I2F (forward: 5
 
9
 
 agcata-
gattccatttgct 3
 
9
 
), with Fas-Z8 (reverse: 5
 
9
 
-caaattttattgttgcgaca-3
 
9
 
)
to identify the 
 
lpr
 
 allele, or Fas-I2B (reverse: 5
 
9
 
-agtaatgggctcagt-
gca-3
 
9
 
) to identify the wild-type 
 
fas
 
 allele. PCR amplifications
were set up in 50-
 
m
 
l vol containing 1 U of AmpliTaq Gold™
(Perkin Elmer Corp.), 1
 
3
 
 buffer II, 250 
 
m
 
M of each dNTP,
2.5 mM MgCl
 
2
 
, and 40 pmol of each primer. Amplifications
were carried out in an OmniGene Hybaid thermocycler (Hy-
baid) under the following conditions: denaturation/enzyme acti-
vation for 9 min at 92
 
8
 
C; then 35 cycles of 30 s each at 94, 56,
and 72
 
8
 
C; final elongation at 72
 
8
 
C for 7 min.
 
B Cell Hybridoma Production.
 
B cell hybridomas were gener-
ated from unmanipulated spleen cells from a 2-mo-old 3H9V
 
k
 
8/
 
lpr
 
 mouse using SP2/0 myeloma cells (25) as the fusion partner.
Spleen cells from 3H9V
 
k
 
8/BALB/c mice were stimulated in
vitro for 3 d with 20 
 
m
 
g/ml LPS (Sigma Chemical Co.) and fused
as previously described (13). Hybridomas were plated at limiting
dilution, and only wells bearing single colonies on 96-well plates
containing 
 
,
 
30 hybrids per plate were expanded for analysis.
 
ELISA Assay for Ig Secretion.
 
Isotypes were determined using
 
an indirect solid-phase ELISA as previously described (26). Plates
were coated with anti-Ig Ab and developed with alkaline phos-
phatase–labeled anti-IgM, anti-IgG, anti-IgA, anti-
 
k
 
, or anti-
 
l
 
.
The enzyme activity was revealed by the substrate 
 
p
 
-nitrophenyl
phosphate (Sigma Chemical Co.) and optical density was read at
405 nm. All commercial Abs were from Southern Biotechnology
Associates, Inc. Samples were titrated, and concentrations were
estimated by comparison to a standard curve.
 
DNA Binding Assays.
 
Binding to ssDNA was measured by
solid phase ELISA. Immunolon
 
®
 
 4 plates (Dynex Technologies,
Inc.) were coated with 60 
 
m
 
l of histone-free protamine (Sigma
Chemical Co.) at 500 
 
m
 
g/ml. Then, 60 
 
m
 
l of boiled and quickly
chilled salmon sperm DNA (90 
 
m
 
g/ml) was allowed to bind to
protamine-coated plates overnight at 4
 
8
 
C in a humid chamber.
The next day, the plates were blocked with PBS containing 1%
BSA. After washing with PBS-Tween, serum samples or hybri-
doma supernatants at various dilutions were added and incubated
for 2 h at 37
 
8
 
C. To detect DNA binders, alkaline phosphatase–
labeled mouse isotype-specific antibody was used (Southern Bio-
technology Associates, Inc.), and the enzyme activity was re-
vealed by the specific substrate 
 
p
 
-nitrophenyl phosphate (Sigma
Chemical Co.). Optical density was read at 405 nm.
Binding to dsDNA was measured by a two-step solution phase
ELISA as previously described (27). In brief, antibody concentra-
tions in the supernatants were first standardized to 2 
 
m
 
g/ml.
Then, supernatants and protein-free calf thymus biotinylated
DNA (1 
 
m
 
g/ml) were mixed, incubated at 37
 
8
 
C for 60 min, and
transferred to microtiter plates (Immunolon
 
®
 
 4; Dynex Technol-
ogies, Inc.) coated with pure avidin (10
 
 m
 
g/ml, 50
 
 m
 
l/well; Avi-
din D; Vector Labs., Inc.). After a 60-min incubation at room
temperature, plates were washed, and DNA–Ab complexes were
detected with alkaline phosphatase–conjugated goat anti–mouse
isotype-specific Ab (Southern Biotechnology Associates, Inc.).
 
Immunofluorescence (ANAs and Crithidia luciliae).
 
Antinuclear
specificities of mAbs and serum Igs were determined by indirect
immunofluorescence staining of HEp-2 cells using an ANA test
kit (The Binding Site, Inc.) according to the manufacturer’s di-
rections. Substrate cells were incubated with culture supernatants
or serum at different dilutions for 20 min, washed in cold PBS/
BSA 1%, and stained with Alexa™ 488 goat anti–mouse IgG
(Molecular Probes, Inc.). Slides were viewed under a Zeiss
LSM510 confocal microscope using a C-apochromat 40
 
3
 
/1.2 NA
water immersion objective. Positive ANAs were further tested
for their capacity to bind dsDNA of the trypanosoma 
 
Crithidia lu-
ciliae
 
 using an anti-nDNA antibody test kit (CrithiDNA; Anti-
bodies Inc.) following the manufacturer’s directions. The proce-
dure is the same as that described for the ANA test.
 
DNA Microextraction and PCR Assays.
 
Genomic DNA was
purified from individual hybrids as previously described (26).
Primers and conditions used for H and 
 
k
 
 chain PCR assays have
already been detailed (references 22, 23, 26, and Fig. 1). A LD/
JHCH PCR was designed (see below) and used as a first ap-
proach to distinguish between 3H9V
 
H
 
 replacement (22) and so-
matic mutation because somatic mutation in the CDR3 of the
3H9 sd-tg was shown to prevent amplification in the LD/CDR3
PCR. All hybrids negative in the LD/CDR3 PCR were tested
with the LD/JHCH PCR. This PCR is not as specific as the LD/
CDR3 PCR, because the JHCH primer is not sd-tg specific, and
the 3H9 leader primer binds V genes with similar leader se-
quences. Hence, 3H9 sd-tgs with mutations in CDR3 as well as
V
 
H
 
 replacements where the invading V
 
H
 
 gene uses a 3H9-like
leader sequence will be detected in this assay. All PCR amplifica-
tions were carried out in a TouchDown thermocycler (Hybaid). 
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All primers were made by the Princeton University Synthesizing/
Sequencing Facility.
 
V
 
H
 
 and V
 
k
 
 Genomic DNA Sequencing.
 
Genomic DNAs from
individual hybridomas were used as templates from which to am-
plify V
 
H
 
 and V
 
k
 
 genes. PCR amplifications were set up in a 30 
 
m
 
l
vol containing 1 U of AmpliTaq Gold™ (Perkin Elmer) 1
 
3
 
buffer II, 200 
 
m
 
M of each dNTP (Boehringer Mannheim), 50
pmol of each primer, and 1.5 mM MgCl
 
2
 
 (Perkin Elmer). The 5
 
9
 
primers used to amplify V
 
H
 
 regions were either LD3H9 (5
 
9
 
-ctgt-
caggaactgcaggtaagg-3
 
9
 
) or VH5.3 (5
 
9
 
-(g/c)aggt(g/t)cagctgcag(g/c)
agtctgg-3
 
9
 
) in combination with a primer located in the JH–CH
intron (JHCH: 5
 
9
 
-cttctctcagccggctccctc-3
 
9
 
). For PCR detection
of V
 
k
 
 genes, the forward primers were either specific for V
 
k
 
8
(MW133: 5
 
9-ggtacctgtgggacattgtg-39) or degenerate Vs (59-ggct-
gcag(c/g)ttcagtggcagtgg(a/g)tc(a/t)gg(a/g)ac-39) (28) and the re-
verse primer was a primer specific for the Jk–Ck intron
(MW176: 59-tgccacgtcaactgataatgagccctctc-39). Amplifications
were carried out with a thermal reactor (subambient Touch-
Down; Hybaid) as follows: VH: 928C for 9 min, followed by 38
cycles of denaturation for 45 s at 948C, annealing for 50 s at
568C, extension for 1 min and 40 s at 728C, and a final extension
of 7 min at 728C. Vk8: 928C for 9 min, followed by 38 cycles of
denaturation for 30 s at 948C, annealing for 30 s at 568C, exten-
sion for 30 s at 728C, and a final extension of 7 min at 728C. Vs:
38 cycles of denaturation for 30 s at 948C, annealing for 40 s at
658C, extension for 1 min and 40 s at 728C, and a final extension
of 7 min at 728C. Each fragment was size selected on a 1.5% aga-
rose gel (Ultra Pure Agarose; GIBCO BRL) and purified by
QIAquick gel extraction (Qiagen Inc.). Nucleotide sequencing
was performed using the ABI Prism™ Big Dye™ Terminator
Cycle Sequencing Ready Reaction Kit with AmpliTaq® DNA
polymerase, FS, according to the manufacturer’s directions (Ap-
plied Biotechnology, Inc.). Reactions were run on the Applied
Biosystems 377 PRISM automated DNA sequencer (PE Applied
Biosystems).
Vk23 mRNA Sequencing. Total RNA was isolated from hy-
bridomas using the RNAeasy kit (Qiagen Inc.), and 10 mg RNA
was converted into cDNA using avian reverse transcriptase
(Promega Corp.) and an oligo-dT/random hexamer primer mix-
ture. 1 ml of cDNA was then amplified by PCR using Vs (28) as
a forward primer and Ck-specific primer as a reverse primer (Ck:
59-tggatggtgggaagatg-39). The PCR program was as follows: 35
cycles consisting of 20 s at 948C, 40 s at 558C, and 90 s at 728C.
A Taq enzyme activation step of 9 min at 928C was performed
before the first cycle, and a final extension step of 7 min at 728C
ended the program. PCR products were purified on a gel with
the QIAquick gel extraction kit (Qiagen Inc.) and were se-
quenced with the ABI prism system. For each sequence identified
as Vk23, cDNA was also amplified using a Vk23 primer specific
for the framework (FW)1 (Vk23: 59-gatattgtgctaactcagtctccagc-
cac-39) and the same Ck-specific primer. PCR products were se-
quenced as described above.
Sequencing of MRL/lpr Vk23 Germline Genes. Genomic DNA
was extracted from the tails of two MRL-lpr/lpr mice as described
above. 1 ml of DNA was used in a PCR containing 50 pmol of a
Vk23 forward primer specific for the FW1 region (Vk23F: 59-
gatattgtgctaactcagtctccagccac-39), 50 pmol of Vk23 reverse
primer complementary to the FW3 region (Vk23R: 59-gaggc-
cagctgttactctgttg-39), 1.5 mM MgCl2, 200 mM dNTPs, 3 ml 103
buffer II, and 1 U AmpliTaq Gold™ (Perkin Elmer). The PCR
program was as follows: 928C for 9 min, followed by 35 cycles of
denaturation for 30 s at 948C, annealing for 30 s at 608C, and ex-
tension for 40 s at 728C. A final extension step at 728C was car-
ried out for 7 min. PCR products were size selected on a 1.5%
agarose gel (Ultra Pure Agarose; GIBCO BRL) and purified with
the QIAquick gel extraction kit (Qiagen Inc.). Purified DNA
fragments were cloned into the pGEM®-T easy vector (Promega
Corp.). JM109 competent cells were transformed by electropora-
tion, and transformants were directly tested for the nature of the
insert by PCR, using two different sets of Vk23-specific primers.
One set was made up of the Vk23 primers used in the initial am-
plification (see above) and another set was made up of Vk23
primers (Vk239F: 59-gtgactccaggagatagc-39; Vk239R: 59-gttg-
ataccagtgtaggtt-39) specific for the new Vk23 gene (Vk23GL2)
similar to our Vk23 sequences (see text). Plasmid DNA from
positive colonies of each group was sequenced as described above
using a plasmid-specific T7 primer. Two Vk23 germline se-
Figure 1. Positions of PCR primers in IgH and Igk loci in 3H9Vk8
mice. Locations of primers used to assess the rearrangement status of both
targeted and untargeted H chain (a) and L chain (b) alleles are shown. H
chain primers: LD, CDR2, and CDR3 are primers specific for the tar-
geted H chain (12, 22). JHCH binds in the JH-CH intron of both H
chain alleles (see Materials and Methods). DH59 is a degenerate primer
that binds 59 of DH gene segments (except DSP.2 and DFL16.2) and can
be used to detect D gene invasion (22) on the targeted allele and partial
DJ rearrangements on the untargeted allele. VH5.3 is another degenerate
primer specific for the FW3 of z65% of VH genes; VH5.3 is used to de-
tect VH replacement (22). The JH1 up primer set is used to detect unrear-
ranged untargeted alleles. Any DJ rearrangement on this allele results in
deletion of the JH1up sequence. L chain primers: 8R primers are specific
for the targeted L chain (12, 23). Both Vs (28) and L5 (48) are forward
Vk primers; the former detects 80% of Vk genes, and the latter 50–60%.
Vs and L5 in combination with Jk2 or Jk5 reverse primers are used to de-
tect Vk-Jk rearrangements. Sp2/0 L chain locus: Sp2/0 has been used as
the hybridoma fusion partner (25). It harbors a nonproductive Vk-Jk2 re-
arrangement that is bound by Vs but not L5. Figures are not drawn to scale.694 Peripheral Light Chain Rearrangement in Autoimmunity
quences were identified. One was identical to the DP12 mAb se-
quence (4) and was not amplified by the second set of primers.
The other one differed from the DP12 sequence by two nucle-
otides located in the FW1 and CDR2 (see Fig. 5) and was ampli-
fied with the Vk239 primers.
Sequence Analysis. Sequences were analyzed for homology to
the original 3H9 and Vk8 transgenes as well as to published Ig
gene segments using EMBL/GenBank databases and Kabat et al.
(29). The sequences of 3H9 VH gene and the Vk8 gene can be
found in EMBL/GenBank/DDBJ databases under the accession
numbers M18234 (3H9) and M34742 (Vk8). The Vk23 sequences
described in this paper are available from EMBL/GenBank/DDBJ
under the following accession numbers: AF139842–AF139849.
The accession numbers for the VH sequences presented in Fig. 3
B are AF145959–AF145963.
Statistical Analysis of Clonal Trees. We tested the hypothesis
that mutations accumulated at the same rate and for equal dura-
tion at three loci. Under the assumption that all three loci mutate
at the same rate, we reasoned that if the three genes had mutated
for equal lengths of time, they should have equal numbers of mu-
tations per base. We used the genealogical trees to determine the
number of independent mutations (the total sum of the branch
lengths in each tree) that occurred at each of the three loci. By
this measure, 3H9, Vk8, and Vk23 loci accumulated M3H9 5 34,
MVk8 5 33, and MVk23 5 18 mutations (see Fig. 6), respectively,
in sequences of length of L3H9 5 363 bases, LVk8 5 339 bases, and
LVk23 5 324 bases (see Figs. 3 A, 4, and 5). We used only muta-
tions in the coding sequences for this analysis.
Assuming the hypothesis is true and an underlying Poisson dis-
tribution of mutations, we determined the mean number of mu-
tations per base ( ) from the maximum likelihood estimate, in
this case, the average:
(1)
Under the null hypothesis (H0: mutation for equal duration at
three loci), the number of mutations in each sequence ( ,
etc.) would be determined by the same value of   mutations per
base estimated by   above. Our hypothesis amounts to equating
the three individual mutation frequencies l3H9, lVk8, and lVk23 to
a common frequency  . Thus, the total number of mutations
in the three sequence sets would be governed by Poisson distri-
butions with means  ,  , and
. Put formally: H0: ,
i.e., all have the same number of mutations per base, meaning
the same duration of mutation. We tested the alternative: HA:
 using the following statistic:
(2)
The next section describes how Z0 was derived. The alternative
hypothesis includes the statement that  , so we esti-
mated their common value by:
(3)
 is estimated by  . Under H0, these two formu-
las estimate the same quantity. Thus under H0, the expectation of
their difference:
l0
l ˆ 0
M3H9 Mvk8 Mvk23 ++
L3H9 Lvk8 Lvk23 ++
--------------------------------------------------- èø
æö 85
1026
----------- 0.08285. == =
M3H9
l0
l ˆ 0
l0
M3H9 L3H9l0 = Mvk8 Lvk8l0 =
Mvk23 Lvk23l0 = l3H9 lvk8 lvk23 l0 == =
lvk23 l3H9 <l vk8 =
Z0
M3H9 Mvk8 +
L3H9 Lvk8 +
------------------------------- èø
æö Mvk23
Lvk23
------------- èø
æö –
l ˆ 3H9 l ˆ vk8 + ()
L3H9 Lvk8 + () 2 ---------------------------------- l ˆ vk23
Lvk23 () 2 ------------------- +
---------------------------------------------------------------- . =
l3H9 lvk8 =
M3H9 Mvk8 +
L3H9 Lvk8 +
------------------------------- èø
æö l ˆ 3H9 l ˆ vk8. ==
l ˆ vk23 Mvk23 Lvk23 ¤
(4)
is zero. To obtain a standardized (mean 5 zero, variance 5 one)
statistic, namely Z0, under H0, we divided the difference by the
square root of its estimated variance, which we calculated as fol-
lows. The variance of a difference is the sum of the terms’ sepa-
rate variances, which is:
(5)
M3H9 Mvk8 +
L3H9 Lvk8 +
------------------------------- èø
æö Mvk23
Lvk23
------------- èø
æö –
Var
M3H9 Mvk8 +
L3H9 Lvk8 +
------------------------------- èø
æö Var
Mvk23
Lvk23
------------- èø
æö +
Var M3H9 Mvk8 + ()
L3H9 Lvk8 + () 2 ---------------------------------------------- è
æ Var Mvk23 ()
Lvk23 () 2 ---------------------------- ø
ö +
Var M3H9 () Var Mvk8 () +
L3H9 Lvk8 + () 2 ------------------------------------------------------------- è
æ Var Mvk23 ()
Lvk23 () 2 ---------------------------- ø
ö. +
=
=
Figure 2. Immunofluorescence staining of HEp-2 cells by 3H9Vk8/lpr
serum and hybridoma supernatants. HEp-2 cells were incubated with su-
pernatant from hybridomas (15, 28, 38, 50, 83, and 79) or 1:500 diluted
serum from 3H9Vk8/lpr and 3H9Vk8/BALB/c mice. Serum Ig from
3H9Vk8/lpr mice and all hybrids but 79 showed similar ANA patterns
compatible with DNA or DNA–protein complex staining. Hybridoma
79 and sera from 3H9Vk8/BALB/c mice gave the same negative pattern.695 Brard et al.
Table I. Characterization of Hybridomas Derived from Anti-ssDNA sd-tg Mice in Both the MRL-lpr/lpr and the Nonautoimmune BALB/c 
Genetic Backgrounds
Mouse Genotype
Hybrids* Isotype‡ DNA binding*‡
LD/CDR3 LD/JHCH Sequencing M/G ssDNA§ dsDNA
3H9V k8/lpr 3H91Vk81 33 (69) 38 (79) 38 (79) 26/7 25 (75) 4 (12)
3H91Vk82 1 (2) 1 (2) 1 (2) 0/1 0 (0) 0 (0)
3H92Vk81 12 (25) 7 (15) 7 (15) 3/9 0 (0) 5 (42)
3H92Vk82 2 (4) 2 (4) 2 (4) 0/2 0 (0) 0 (0)
Total 48 (100) 48 (100) 48 (100) 29/19 25 (52) 9 (19)
3H9V k8/BALB/c 3H91Vk81 65 (88) – – 65/0 65 (100) 0
3H91Vk82 1 (1) – – 1/0 0 0
3H92Vk81 8 (11) – – 8/0 0 0
3H92Vk82 0 (0) – – 0/0 0 0
Total 74 (100) – – 74/0 65 (88) 0
Results are from a single mouse for each genetic background. Both mice express the H and L chain sd-tgs 3H9 and Vk8 in a heterozygous state
(3H9/1;Vk8/1). The lpr-derived hybridomas were generated from unmanipulated splenic B cells, whereas the BALB/c hybrids were derived from
in vitro LPS-stimulated splenocytes. DNA binding activities of hybridoma supernatants were determined by solution phase ELISA as described in
Materials and Methods. Clonally related hybrids are included in this table.
*Numbers in parentheses refer to the percentage of hybrids in each category. Other numbers represent the number of hybrids testing positive or
negative for 3H9 and Vk8 sd-tgs by PCR as described in Materials and Methods. In the “sequencing” column, the actual number of hybrids in each
category based on nucleotide sequences is given.
‡To ease comparison with the 3H9Vk8 BALB/c data, the different categories of “DNA binding” and “Isotype” were presented in accordance with
the LD/CDR3 PCR.
§ssDNA refers to the hybrids that secrete anti-ssDNA mAbs with no dsDNA activity.
Table II. Genetic Characteristics of the IgG-secreting Hybridomas from a 3H9Vk8/lpr Mouse
Hybridoma Subtype
dsDNA binding H Chain L Chain
dsDNA ANA VH gene JH Mut./Rep. Vk gene Jk Mut./Ger.
50 IgG2a 1 111 3H9 4 Mut 8; 23 5/29 Mut
79 IgG2a 111 – 3H9 4 Mut 8; 23 5/29 Mut
15 IgG2a 111 111 3H9 4 Mut 8; 23 5/29 Mut
83 IgG2a 111 111 3H9 4 Mut 8; 23 5/29 Mut
28 IgG2a 111 111 3H9 4 Mut 8; 23 5/29 Mut
38 IgG2a 1 111 3H9 4 Mut 8; 23 5/29 Mut
46 IgG1 11 – 3H9 4 Mut 8 5 Ger
16 IgG3 1 – 3H9 4 Mut 8 5 Mut
57 IgG1 111 – J558 4 Rep 8 5 Ger
85 IgG1 – – J558 4 Rep 8 5 Ger
13 IgG3 – – J558 4 Rep 8 5 Ger
1 IgG2b – – 7183 4 Rep 8 5 Mut
2 IgG1 – – 7183 4 Rep 8 5 Mut
49 IgG1 – – ND 4 ND 8 5 Mut
Jk29 is an allelic variant of the Jk2 segment that is found in MRL-lpr/lpr mice. The number of 1 symbols is a measure of the optical density (ds-
DNA) or intensity of fluorescence (ANA) obtained using the anti-dsDNA mAb (Mx3828) as a reference. Mx3828 was derived from a 3H9Vk8/lpr
mouse. Mut., mutated; Rep., replacement; Ger., unmutated in comparison to the Vk8 sd-tg.696 Peripheral Light Chain Rearrangement in Autoimmunity
Figure 3 (continues on facing page).
The variance of a Poisson deviate is equal to its mean, thus,
(6)
and similar formulas hold for   and  . Thus,
the variance of the difference is:
(7)
This quantity is estimated by substituting the above estimates of
the  ’s for their true values. For these data, Z0 5 2.063.
We sampled the Poisson distribution with parameters  , i 5
3H9, Vk8, Vk23 to obtain deviated  ,  , and  ,
rigorously under H0. From these, a new   was obtained as
above, and finally, a new value of Z was derived. If the new Z
was at least Z0, the event was tallied. The procedure was repeated
100,000 times. In these trials, Z0 was equalled or exceeded only
1,780 times, requiring H0 to be rejected at the 1.78% level.
Results
Anti-DNA Abs Arise Spontaneously in 3H9Vk8/lpr Mice.
In nonautoimmune mice, 3H9Vk8 B cells are anergized.
Var M3H9 () M3H9 L3H9l0 ==
Var Mvk8 ()Var Mvk23 ()
l3H9 lvk8 +
L3H9 Lvk8 + ()
2 ----------------------------------
lvk23
Lvk23 ()
2 ------------------ . +
l
Mi
M3H9 Mvk8 Mvk23
l ˆ 0
Consequently, 3H9Vk8 transgenic mice have no detect-
able DNA binding activity in their serum (12). To assess
whether such anergic B cells escape tolerance in autoim-
mune MRL/lpr mice, sera from 3H9Vk8/lpr mice were
tested for the presence of anti-DNA Abs. Anti-DNA Abs
were readily detected by ELISA as well as by indirect im-
munofluorescence on Crithidia luciliae (data not shown).
Furthermore, ANAs were detected in the sera of 3H9Vk8/
lpr as early as 2 mo of age. None of these Ab specificities
was detected in sera from 3H9Vk8/BALB/c mice (Fig. 2
and data not shown).
Anti-DNA B Cells Are Activated in 3H9Vk8/lpr Mice.
Hybridomas from 3H9Vk8/lpr mice have many features
that indicate 3H9Vk8/lpr B cells are activated rather than
anergic, as they are in the BALB/c background. Unmanip-
ulated 3H9Vk8/lpr B cells yield high frequencies of hybri-
domas, unlike 3H9Vk8/BALB/c B cells, which require
LPS stimulation or immunization for hybridoma forma-
tion. In this regard, 3H9Vk8/lpr B cells are similar to those
of diseased, nontransgenic, MRL/lpr mice that generally
have high spontaneous fusion efficiencies (30). A high per-
centage of spontaneous hybridomas from diseased mice697 Brard et al.
Figure 3. Nucleotide and deduced amino-acid sequences of hybridoma H chains. (A) Sequences of the 3H9 sd-tg in IgG-secreting hybridomas (50,
79, 15, 83, 28, 38, 46, and 16). The sequence of the 3H9 sd-tg is shown. Identities are indicated with dashes. CDRs are defined according to Kabat et
al. (29). Unmutated sequences from IgG-secreting hybridomas are not presented in this figure. Mutations shared by at least two sequences are shaded ex-
cept for the first two, which result from the degenerate nature of the VH5.3 primer used in amplification. (B) VH replacement sequences. In these hybri-
domas (57, 85, 13, 1, and 2), the 3H9 sd-tg has been replaced by an upstream VH gene, via the embedded heptamer at the end of CDR3 in 3H9 (22).
The sequence of the 3H9 sd-tg is used as a reference for the hybridomas 57, 85, and 13 because the replacing genes belong to the same J558 gene family.
Boxed residues at positions 53, 57, and 65 are specific to the 3H9 gene (mutations). Identical nucleotides between hybridomas 57 and 85 are shaded
when different from 3H9. These two hybrids represent potential members of the same clone (see text). The sequence of hybridoma 13 is also compared
with the unmutated H chain sequence of mAb 19.1.2, which uses a more related J558 gene (sequence data available from EMBL/GenBank/DDBJ under
accession number AJ223534). Identical nucleotides between hybridoma 13 and the reference J558 gene are also shaded. The D segment used in hybri-
doma 13 has homology with DQ52 (59 boundary) and DSP2.6-c (39 boundary) gene segments, probably resulting from a D–D fusion. Sequences from
hybridomas 1 and 2 are compared with two different genes from the 7183 gene family, EMBL/GenBank/DDBJ accession numbers AF003722 and
Z22078, respectively. In hybridoma 1, the D segment has homology with both the DSP2.9 (59 boundary) and the DSP2.10-c (39 boundary) gene seg-
ments, and in hybridoma 2, with both the DSP2.10 (59 boundary) and the DFL16.1E (39 boundary) gene segments. The regions of homology are under-
lined and identical nucleotides are in bold.
produce autoantibodies such as anti-DNA and RF suggest-
ing that self-antigens are driving fusable B cells (31). Hybri-
doma panels from 3H9Vk8/lpr mice also have high fre-
quencies of anti-DNA-secreting B cells. For example, in
one hybridoma panel derived from a 2-mo-old 3H9Vk8/lpr
mouse, 34 (71%) out of 48 hybridomas secreted anti-DNA
Abs (Table I). This is not surprising given that the tg Ab
binds ssDNA, but of these 34 hybridomas, 9 bound ds-
DNA in ELISA, and of these, 5 displayed a homogeneous
nuclear staining pattern on HEp-2 cells (Fig. 2). Anti-dsDNA
and ANAs are rarely found in hybridoma panels from LPS-
activated B cells from 3H9Vk8/BALB/c mice; instead,
most of these hybridomas produce anti-ssDNA Abs (refer-
ence 13 and Table I). Finally, the presence of isotype-
switched anti-DNA Abs in the serum of 3H9Vk8/lpr and
the secretion of IgG by 40% of the hybridomas (Tables I
and II) are other indications of antigen activation. Strik-
ingly, all the dsDNA/nuclear binders are IgG. Together,
these results provide strong evidence that these mice are
undergoing a (self-)antigen-driven immune response.
The Genetic Basis of Anti-DNA in 3H9Vk8/lpr Mice: Mu-
tation. Anti-dsDNA/ANAs in 3H9Vk8/lpr mice could be
generated either by somatic mutation or by gene replace-
ment. To distinguish mutation from replacement, we ex-
amined the status of the H and L chain sd-tgs. Those hybri-
domas that retain both the 3H9 H and Vk8 genes but
express unique specificities are likely to be mutated. Those
that have lost 3H9 and/or Vk8 gene(s) would most likely698 Peripheral Light Chain Rearrangement in Autoimmunity
have specificities generated de novo. We tested for the
presence of VH and Vk transgenes in hybridomas from the
3H9Vk8/lpr mouse using a series of PCR assays (Fig. 1).
Out of 48 hybridomas studied, 38 (79%) were positive for
both the 3H9 and Vk8 genes. Of these double-positive hy-
bridomas, some did not bind DNA, whereas others have
acquired specificity for anti-dsDNA (Table I), suggesting
that the 3H9 and/or Vk8 transgenes have undergone so-
matic mutation. Similar results were obtained from a hybri-
doma panel of a 4-mo-old 3H9Vk8/lpr mouse (Brard, F.,
and M. Weigert, unpublished data).
The VH genes of 13 IgG-secreting hybridomas with
changed specificity (anti-dsDNA/ANA1 or non-anti-
DNA) were amplified and sequenced. Of these, eight were
3H91Vk81 mutants and five were 3H92Vk81. Their nu-
cleotide and deduced amino-acid sequences are shown in
Fig. 3, A and B, and are summarized in Table II. Mutations
in the 3H9 sd-tg are located both in the coding and in the
noncoding regions. The average number of mutations per
V region is high, 12.5, with the most mutated V region
having 22 mutations (hybridoma 28) and the least mutated
having 6 (hybridoma 16) (Fig. 3 A). In the JHCH intron,
the average number of mutations within the 60 bp imme-
diately 39 of JH4 is 2.4, with the most mutated sequence
having 5 mutations. Of note, hybridoma 46 has a deletion
of three codons in CDR2. In the same region, hybridoma
Figure 4. Nucleotide and deduced
amino-acid sequences of the Vk8 sd-tg
in IgG-secreting hybridomas. The Vk8
sd-tg sequence is used as a reference.
Identities are indicated with dashes.
CDRs are defined according to Kabat et
al. (29). Mutations shared by at least two
sequences are shaded. Only mutated
Vk8 sequences are presented (10 out of
46). Six sequences display a stop codon
at the beginning of the CDR1.699 Brard et al.
28 has a stretch of five nucleotides that are different from
their germline counterparts. We think this most likely re-
sults from some form of insertion and deletion. Wilson et
al. (32) described similar insertion/deletion mutants in Ig
hypervariable loops. In their study, deletions occurred at
tandem repeat sequences and inevitably destroyed one of
the tandem repeats. Insertions usually involved duplications
of the immediately adjacent sequence. In 3H9’s CDR2, we
have identified such a repeat sequence, AGA GAT GGA
GAT, at the site of the insertion/deletion mutations. The
deletion in hybridoma 46 removes one full repeat element
plus one adjacent codon. The sequence of the insertion in
hybridoma 28, GAGTC, is similar to the repeat motif
GAGAT. Interestingly, the GAGAT motif contains the
putative hot spot sequence RGYW (33), and it is known
that deletion/insertion events usually occur in the vicinity
of mutational hot spots (32).
Mutations were also found in 10 of the Vk8 sd-tgs (Fig.
4). Here again, mutations were found throughout the se-
quence. The average number of mutations per V region
was 9.2, ranging from 18 mutations (hybridoma 50) to 3
mutations (hybridoma 16). All together, many of the VH
and VL genes sequenced from the hybridomas presented in
Table II have replacement mutations in CDRs. Thus, it is
possible that the novel specificities of these antibodies are
the result of mutation in the 3H9 and/or Vk8 genes.
Clonal Expansion. Hybridomas 50, 79, 15, 83, 28, and
38 share eight mutations in their 3H9 sequences, therefore
it is likely that they come from an expanded B cell clone.
Ordinarily, B cells are defined as members of a clone based
not only on the presence of shared mutations but also on
sequence identity of VHCDR3. However, sequence iden-
tity of VHCDR3 is not an applicable criterion by which to
judge clonality in transgenic models. Nevertheless, the fol-
lowing observations indicate that these six hybridomas are
indeed derived from a single B cell clone: first, these hybri-
domas all express the same isotype, IgG2a. Second, these
hybridomas also share 15 mutations in their Vk8 and 3H9
sd-tgs, collectively. Third, each of these hybridomas main-
tains a germline H chain allele and has identical endoge-
nous k chain rearrangements (see below). Furthermore, it
is unlikely that the shared mutations are entirely the result
of positive selection and/or hotspot mutation, because only
two of these shared mutations are found in the sequences of
hybridomas that we know to be unrelated on the basis of
rearrangement status (hybridoma 46, Fig. 3 A, and hybri-
Figure 5. Nucleotide and deduced
amino-acid sequences of Vk23 from B
cell clone members. Hybridomas that
had a nonsense mutation in their Vk8
gene were tested for the presence of an-
other L chain by sequencing L chain
mRNA. All six hybridomas express a
Vk23 L chain. These sequences are
compared with two Vk23 germline
genes, Vk23GL1 and Vk23GL2, ob-
tained from MRL/lpr tail DNA. Identi-
ties are indicated with dashes. Mutations
shared by at least two members are
shaded. T and C nucleotides located at
the V-J junction are likely to result from
the germline segments and therefore are
not considered as mutations or N-addi-
tions. The CDRs are defined according
to Kabat et al. (29). In all sequences, the
Vk23 gene is rearranged to a Jk29 gene
segment. Jk29 is an MRL/lpr allelic vari-
ant of Jk2 that occupies the same chro-
mosomal position as Jk2 relative to
other Jks. It has a serine at position 100
(boxed) instead of the glycine of Jk2.
The usage of a Jk29 segment demon-
strates that the Vk gene rearranged on
the untargeted allele of the MRL/lpr
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doma 2, Fig. 4); moreover, 7 out of the 15 shared muta-
tions in both H and L transgenes are nonselectable, either
because they are silent or because they occur in introns.
The most interesting feature of this clone is that all
members share a mutation to the TAG nonsense codon in
the Vk8 sd-tg at the beginning of the CDR1 (Fig. 4). Be-
cause these clones secrete an IgG2a/k Ab, the untargeted k
allele must be rearranged and expressed. To determine the
nature of the expressed L chain, Vk mRNA from these six
hybridomas was sequenced (Fig. 5, Table II). All express a
Vk23 gene joined to Jk29, the MRL counterpart of Jk2.
Analysis of the V–J junction revealed that the first codon of
Jk29 is deleted and a histidine is found in its place. This un-
usual junction has previously been observed in other
Vk23Jk29 sequences (18, 34). The histidine found at the
junction may derive from either the end of the germline
Vk23 gene or the nucleotides immediately 39 of the Vk23
gene.
To evaluate the number of mutations in the Vk23 se-
quences, it was necessary to determine the germline se-
quence of the Vk23 gene. Because GenBank did not con-
tain an appropriate sequence, we cloned Vk23 genes from
MRL/lpr tail DNA. Two potential candidates, Vk23GL1
and Vk23GL2 (Fig. 5) were identified. Our six hybridoma
Vk23 sequences are most similar to Vk23GL2. Assuming
that Vk23GL2 is the bona fide germline counterpart, the
Vk23 sequences from our hybridomas had an average of
6.5 mutations per V region, with the most mutated V re-
gion having 10 mutations (hybridoma 28) and the least mu-
tated having 5 (hybridomas 38 and 83). These six sequences
have three mutations in common, and two other mutations
are shared by at least four out of the six clone members.
The shared VH and Vk mutations form a hierarchy char-
acteristic of expanded clones. This hierarchy of mutations
allowed us to construct a genealogy of the clone members
(Fig. 6). The 3H9 and Vk8 trees have roughly the same
height and shape. This similarity illustrates that the onset
and rate of mutation are the same in H and L chain genes.
Although the Vk23 tree has a “branch morphology” simi-
lar to that of the 3H9 and Vk8 trees, it appears to have a
shorter “trunk.” Furthermore, the average number of mu-
tations is less in Vk23 than in either 3H9 or Vk8 (6.5 com-
pared with 14 and 13, respectively). These results indicate
that the Vk23 L chain started to mutate later than the Vk8
or 3H9 transgenes, but that once initiated, Vk23 mutation
proceeded at a similar rate. Taken together, these mutation
patterns and tree shapes imply that the Vk23 gene was rear-
ranged and expressed after the onset of mutation in the
3H9 and Vk8 transgenes.
To confirm this conclusion, a statistical analysis testing
the hypothesis that mutations accumulated for equal dura-
tions at the three loci was performed. Implicit in this calcu-
lation is the assumption, based on the absence of clear evi-
dence to the contrary, that the mutation rate was equal at
each of these three loci. We also assumed that the number
of mutations found in each tree would be Poisson distrib-
uted. We estimated mutation frequencies per base from the
number of mutations divided by the number of bases in the
corresponding sequence set. The frequency estimates for
our 3H9 and Vk8 trees did not differ significantly, and in
fact were very close to each other. We combined the 3H9
and Vk8 data and compared their combined frequency es-
timate to that obtained for the Vk23 sequences. To test the
significance of this difference, we combined all three data
Figure 6. Genealogical relationships
between antinuclear B cells from a
3H9Vk8/lpr mouse. Genealogical trees
based on the coding sequences of the
3H9 (A), Vk8 (B), and Vk23 (C) genes
from the clonally related hybridomas are
shown. The trees are constructed from
patterns of shared and unique mutations
by assuming that shared mutations rep-
resent single events and not independent
parallel mutations and by assuming the
minimum number of mutational events.
To construct the 3H9 and Vk8 trees, it
was sometimes necessary to assume that
a specific nucleotide underwent two dif-
ferent mutations. For example, in the
3H9 tree we assumed all members of the
clone originally had the silent C®T
mutation in the serine of FW3 and that
subsequently hybridoma 79 underwent a
T®A mutation at the same position.
This explains why there are eight shared
mutations in the stem of the 3H9 tree,
whereas Fig. 3 A shows only seven cod-
ing region mutations shared by all mem-
bers of the clone. The length of the line
between each B cell is proportional to
the number of mutations (given in pa-
rentheses). Note the similar shapes and
branch morphology of the three trees.701 Brard et al.
sets for an overall estimate of mutation frequency. We then
simulated mutations in the three trees by generating Pois-
son deviates with means adjusted for each gene’s particular
sequence length. We tallied the number of times the differ-
ence in mutation frequencies observed this way, (i.e., rig-
orously, under the null hypothesis of identical mutation
durations for each sequence), was as large or larger than
their actual observed difference. Their observed difference
was equalled or exceeded in only 1.78% of 100,000 trials.
This allowed us to reject the hypothesis that all three Ig loci
mutated for equal duration (p 5 0.0178). Therefore, we
conclude that the Vk23 L chain gene was rearranged in the
periphery and then started to undergo somatic mutation.
All members of this clone have acquired dsDNA speci-
ficity, and five out of six are ANA1 (Fig. 2). The acquisi-
tion of dsDNA and antinuclear activity could be due to
mutation in either 3H9 or Vk23. In particular, the muta-
tions to asparagine in FW3 and CDR3 in Vk23 might cre-
ate anti-DNA specificity (35). Alternatively, the Vk23 L
chain itself may create the ANA specificity (Table II), since
ANAs and antihistone antibodies derived from autoim-
mune mice are often associated with Vk23 L chains (18,
19, 34, 36–38).
Discussion
Earlier studies examined the regulation of the 3H9 H
chain tg in lpr/lpr mice (18, 19). The 3H9 H chain trans-
genic without an accompanying L chain transgene is an ex-
cellent model for studying tolerance and loss thereof: the
VH gene coding for 3H9 is the most popular VH among
disease-associated anti-DNAs, constituting z20% of the
.200 sequenced anti-DNAs from MRL/lpr, (NZB 3
NZW)F1 and (NZB 3 SWR)F1. An unusual but useful
feature of 3H9 (and other anti-DNA H chains) is that asso-
ciation with different L chains modifies DNA binding.
3H9/L chain combinations fall into three broad classes:
combinations that sustain ss/dsDNA like that of the origi-
nal 3H9/Vk4 combination, combinations that modify
DNA binding as in the 3H9/Vk8 combination that only
binds ssDNA, and combinations that veto DNA binding as,
for example, 3H9/Vk12/13. A study of 3H9 H chain in
combination with a broad variety of endogenous L chains
shows that the proportion of the three classes is z30% ds/ss :
60% ss : 10% non-DNA binding (39). Moreover, certain L
chains in combination with 3H9 yield unique ANA pat-
terns as illustrated in Fig. 2 for the 3H9/Vk23 combination
(21). Thus, 3H9 sd-tg mice yield a spectrum of antibodies,
making the 3H9 sd-tg MRL/lpr a multipurpose system for
studying the breakdown of tolerance. As might have been
predicted, 3H9 tg lpr/lpr mice express the types of anti-
DNAs that are ordinarily edited or inactivated. These in-
clude anti-ds/ssDNA and antibodies that are ANA1. But a
limitation of this model is that the precursor to the patho-
genic anti-DNAs expressed in this lpr/lpr tg cannot be es-
tablished; hence, the site(s) at which tolerance is broken is
unknown. The advantage of the 3H9Vk8/lpr mice de-
scribed here is that the anti-DNA repertoire is limited to
one specificity, anti-ssDNA, that in normal mice is known
to be regulated by anergy (12, 14). That anti-dsDNAs are
now expressed in the 3H9Vk8/lpr means either that aner-
gic cells become activated or that anergy cannot be estab-
lished in lpr/lpr mice. Based on the evidence for Fas-medi-
ated regulation of peripheral B cells (40, 41), we favor the
latter interpretation.
The failure to establish or maintain anergy of anti-
ssDNA leaves the lpr/lpr mouse with a population of B cells
poised for the transition to autoimmune disease. Both in
vivo and in vitro studies have shown that anti-DNAs such
as 3H9Vk8 can be substrates for mutation to dsDNA and
nuclear antigen binding antibodies (39, 42). Here we show
that this transition takes place during clonal expansion of
3H9Vk8 B cells and results in the production of anti-dsDNA
and ANAs typical of disease. In this regard, our results reca-
pitulate the nature of MRL/lpr and other autoimmune
mice. But, during clonal expansion 3H9Vk8/lpr B cells are
actually subjected to two forms of somatic diversification:
first, expanded hybridomas have accumulated a high fre-
quency of mutations. These include mutations to R and N
that could account for the shift of 3H9Vk8 specificity from
ssDNA to ss/dsDNA and the acquisition of antinuclear
specificity (ANA1, Fig. 2). The second form of diversifica-
tion is L chain editing. This event is an indirect conse-
quence of mutation: all members of the clone share a non-
sense mutation in the Vk8-Jk5 gene, therefore IgGk
secretion requires L chain expression from the untargeted
allele. This novel mechanism rescues a defunct B cell. Al-
ternative explanations for this genotype, such as coexpres-
sion of both k genes throughout the lifetime of the clone,
are highly unlikely (p # 0.0178, see Materials and Methods).
V gene rearrangement during clonal expansion is not
surprising in view of the evidence for RAG expression in
germinal centers (43–45). But the relevance of RAG-
mediated recombination to the immune response at this
stage of B cell development has not been established. RAG-
induced DNA nicks (45) may just be another manifestation
of programmed cell death. It is unlikely that secondary re-
arrangement would enhance an ongoing immune response,
because changing either H or L usually will produce a new
specificity (29). Moreover, these new specificities will
rarely, if ever, be propagated because of the lack of antigen
and T cell help. Instead, RAG expression in germinal cen-
ters simply may be a gratuitous part of impending or actual
cell death. This is suggested by the work of Hikida et al.,
who have shown that most of the B cells in germinal cen-
ters that express RAG are undergoing apoptosis (46). In
fact, apoptosis may have been the raison d’être for RAG to
begin with. The earliest B and/or T cell receptor genes
were probably intact V genes, not segmented V, D, and J
genes. These genes may have included sequences homolo-
gous to recombination signals, and primitive vertebrates
may have fixed genes coding for proteins that cut DNA at
these sites. Such cuts may have served to inactivate V genes
or even to kill cells, thereby enforcing allelic exclusion
and/or helping to maintain steady state levels of lympho-
cytes.702 Peripheral Light Chain Rearrangement in Autoimmunity
For a defunct B cell to be rescued by secondary rear-
rangement requires truly exceptional circumstances, but
anti-DNAs such as 3H9/Vk8 provide the conditions for
rescue. First, L chain replacement does not always destroy
DNA binding, because the H chain makes most of the an-
tibody contacts to DNA (42). Hence, specificity for DNA
can be maintained or modified even though Vk8 is re-
placed (i.e., a kind of impotent receptor editing). Second,
the self-specificity of 3H9/Vk8 (and the L chain alterna-
tives that, with 3H9H chain, sustain DNA binding) ensures
that these antibodies will always be exposed to a cognate
antigen. That germinal centers are sites of apoptosis is rele-
vant to this point because the germinal centers are consid-
ered possible sites where the target lupus autoantigens may
be presented. Third, DNA can be thought of as a super-
antigen, in the sense that it is associated with a wide variety
of both self- and foreign proteins. Thereby, as long as a B
cell’s receptor binds DNA, that B cell can present a variety
of T cell epitopes derived from these DNA-associated pro-
teins. Take, for example, a receptor directed to the com-
plex of DNA–histone. Even though L chain replacement
converts the receptor to one that only binds DNA, the re-
ceptor will still bind chromatin and ultimately that B cell
can present histone peptides. Thus, this kind of autoanti-
body will rarely be at a loss for T cell help. 3H9/Vk8 de-
scendents illustrate this strategy: the 3H9/Vk23 receptor
has acquired specificity for dsDNA yet still binds ssDNA,
making it so that the revised B cell can still present the
same T cell epitope(s) as the parental 3H9/Vk8 B cell.
These studies show that expression of anti-DNA in Fas-
deficient mice is influenced in at least two ways: first, B
cells that are anergic in normal mice become activated; sec-
ond, anti-DNA antibodies can arise in defunct B cells by V
gene replacement. Both processes lead to the development
of a spectrum of autoantibodies. Activation of anti-ssDNA
B cells leads to clonal expansion and mutation and some of
these mutations lead to specificity for dsDNA. Thus, an-
ergy is a major tolerance checkpoint in that it prevents low
affinity anti-DNAs from mutating to pathogenic types.
Secondary V gene rearrangement in B cells generates a new
spectrum of specificities that will surely include autospeci-
ficities. These might be formed by novel VH/VL combina-
tions as in antibodies associated with Vk23.
The fact that secondary rearrangements, or editing, cre-
ate autoreactivity in the autoimmune MRL/lpr is paradox-
ical, because in normal B cell development each round of
editing adds to the number of non-autoreactive, mature B
cells an animal can generate from a given set of precursor
cells. How can one account for this difference? The answer
must lie in a cell’s “motivation” for continuing to rear-
range. An immature B cell from a normal individual wants
to make a functional receptor that does not bind too
strongly to surrounding (self-)antigens. A mature cell from
an autoimmune individual, on the other hand, is attempt-
ing to secure positive selection signals by rearranging until
it has a receptor that binds an antigen with high avidity.
This notion stems from the work of Hertz et al., who have
shown that mature B cells experiencing low affinity inter-
actions with antigen tend to initiate recombination, whereas
high affinity antigen interactions abolish recombinase activ-
ity in mature B cells (47). They also point out that this type
of peripheral regulation of receptor editing would tend to
promote autoreactivity. What is not thoroughly considered
by their work is the role of T cell help. And this is what
may be special in the case of autoreactivity, especially of
autoreactivity to DNA. Rescue of a cell that has become
autoreactive through editing rearrangement in the periph-
ery also requires T cell help (specific for autoantigens) that
is extant in autoimmune mice.
Genes that affect the death of autoreactive cells and the
disposal of defunct B cells (such as the fas gene) have a
broad influence on the regulation of autoimmunity. In ad-
dition to extending the survival (and subsequent activation)
of anergic B cells, they may also permit the development of
an inappropriate repertoire by secondary rearrangement.
The ability to detect peripheral editing in MRL mice is
probably greatly enhanced by the lpr mutation that extends
the life of B cells which otherwise would die before having
had enough time to make a new receptor. Moreover, genes
involved in cell death may regulate the concentration or
availability of self-antigen. Casciola Rosen et al. have
shown that the self-antigens targeted in lupus are found on
the surface of apoptotic cells (6). This led them to suggest
that failure to kill cells efficiently could influence self-toler-
ance by limiting the amount of self-antigen. This limitation
may be particularly strict in the bone marrow microenvi-
ronment where the preimmune repertoire is developed. A
shortage of tolerogen could explain why the spectrum of
autoantibodies in systemic autoimmunity is biased toward
molecules released during cell death and could also resolve
the differences between regulation of antibodies directed to
facultative and constitutive self-antigens.
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